CASCADE INVESTMENT GROUP, INC.
Position in ABT — Abbott Laboratories
CIK 919447
Colorado Springs, CO
Position in ABT
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$225,761
-$150,421 QoQ
Shares Held
2,488
-32.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#2,530
of 2,957 holders
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026CASCADE INVESTMENT GROUP, INC. holds $505,372 across 2 Medical Devices names. ABT ranks #2 (44.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EW |
Edwards Lifesciences Corp
|
3,091 | $279,611 | |
| 2 | ABT |
Abbott Laboratories
This page
|
2,488 | $225,761 |
All Filings in ABT
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $225,761 | 2,488 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $376,182 | 3,664 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $461,944 | 3,687 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $493,836 | 3,687 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $501,468 | 3,687 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $459,499 | 3,464 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $378,352 | 3,345 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $289,927 | 2,543 | Shares | Sole | 2024-10-15 | |
| 2024-03-31 | $348,481 | 3,066 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $337,474 | 3,066 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $291,227 | 3,007 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $327,823 | 3,007 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $304,488 | 3,007 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $330,138 | 3,007 | Shares | Sole | 2023-02-27 | |
| No filing history on record for this holder in this stock. | ||||||